On the 9th, Lotte Biologics announced that it had recently signed a Memorandum of Understanding (MOU) with Roche Diagnostics, the diagnostic division of the Roche Group, to advance the productivity and quality of its Contract Development and Manufacturing Organization (CDMO) business.

The MOU, which was signed at Penzberg, where Roche Diagnostics Custom Biotech Center is located, aims to enhance the productivity and quality of Lotte Biologics’ pharmaceutical production. Won-jik Lee, CEO of Lotte Biologics, Rainer Mueller, Vice President of Roche Diagnostics Custom Biotech, and Kit Tang, General Manager of Roche Diagnostics Korea, attended the signing ceremony.

Under the agreement, the t